Overview
Retail Trade

MEDICAL SYSTEM NETWORK Co.,Ltd.

Medical System Network Group operates a regional pharmacy network business across Japan, providing pharmacy management support services including pharmaceutical procurement intermediation (drug network), dispensing system solutions, and accounts receivable securitization support for member pharmacies and clinics. The Group also engages in generic pharmaceutical manufacturing and sales (through Felzenpharma Co., Ltd.), pharmaceutical logistics, pharmacy digitalization support, facility leasing and medical clinic development, hospital/welfare facility catering services, and home nursing care. Its integrated platform model—spanning pharmacy operations, supply chain efficiency, and digital transformation—serves as a comprehensive solution provider for community-based healthcare.

Market Cap
US$95.5M
¥15.3B
EV
US$271M
¥43.4B
StockUS$3.27(¥522)▲+1.16%
US$1 = ¥159.70 (2026-11-12)
LTM EV/EBITDA
7.0
x
LTM EV/EBIT
15.8
x
LTM PER
22.6
x
LTM PBR
0.9
x
Stock vs TOPIX (1Y, base=100)vs TOPIX ▼-12.6%pt
100
Nov 13, 25 – Nov 13, 26StockTOPIX
MC → EV Bridge
US$95.5M¥15.3BMarket CapUS$220M¥35.1B+ DebtUS$39.6M¥6.33B− CashUS$4.88M¥0.78B− Inv. Sec.US$0.90M¥0.14B+ NCIUS$271M¥43.4BEV
AI Briefing
Integrated community healthcare platform: regional pharmacy network, drug procurement intermediation, generic manufacturing and digital pharmacy services across 15 subsidiaries. FY26/3 revenue US$827M (¥132B) with OP margin compressed to 2.5%, down from 3.3% in FY24/3 despite steady top-line growth. Shareholder base is fragmented among founders, investment vehicles and trust accounts, with no single controlling holder evident.
Performance & Balance
Revenue 5Y (US$)
US$668M¥107B'22/3US$686M¥110B'23/3US$722M¥115B'24/3US$766M¥122B'25/3US$828M¥132B'26/3
EBITDA 5Y (US$)
US$42.0M¥6.71B'22/3US$38.3M¥6.12B'23/3US$43.8M¥7.00B'24/3US$41.1M¥6.57B'25/3US$42.1M¥6.73B'26/3
Net Income 5Y (US$)
US$15.0M¥2.39B'22/3US$10.1M¥1.61B'23/3US$11.6M¥1.86B'24/3US$7.90M¥1.26B'25/3US$6.70M¥1.07B'26/3
Capital Structure
33%
67%
EquityD/E 2.04xDebt
Liquidity vs Debt 5Y (US$)▼ Net Debt
CashInv. Sec.Debt
US$52.3M¥8.36BUS$185M¥29.6B'22/3US$52.0M¥8.30BUS$191M¥30.5B'23/3US$53.0M¥8.46BUS$183M¥29.2B'24/3US$57.4M¥9.16BUS$187M¥29.8B'25/3US$52.6M¥8.41BUS$236M¥37.7B'26/3
Business Segments
2026/03 · US$ (¥B)
95%
Community pharmacy network segment
Revenue
US$796M(¥127B)
Segment profit
US$37.7M(¥6.03B)4.7%
2.5%
Rental facility related
Revenue
US$21.2M(¥3.38B)
Segment profit
US$0.97M(¥0.16B)4.6%
1.7%
lunch catering business
Revenue
US$14.3M(¥2.29B)
Segment profit
-US$0.11M(¥-0.02B)-0.8%
0.3%
Other
Revenue
US$2.10M(¥0.34B)
Segment profit
-US$0.14M(¥-0.02B)-6.5%
Adjustments
Revenue
-US$6.26M(¥-1.00B)
Segment profit
-US$17.7M(¥-2.83B)
No segment changes in the last 5 years
Shareholders
Top 10 hold 56.4%
1
S&S Godo Kaisha
9.28%
2
Yasuyuki OKINAKA
8.40%
3
Hikari Tsushin K.K. Investment Business Limited Liability Partnership
7.52%
4
Jiro AKINO
7.45%
5
The Master Trust Bank of Japan, Ltd. (Trust Account)
6.82%
6
UH Partners 2 Investment Limited Partnership
5.64%
7
Kusurinomadoguchi,Inc.
3.25%
8
MEDICAL SYSTEM NETWORK Co.,Ltd. Employee Stock Ownership Association
3.09%
9
Inao TAJIRI
2.79%
10
INTERACTIVE BROKERS LLC (Standing Proxy: Interactive Brokers Securities Japan Inc.)
2.11%
Management
17 officers
Inao TAJIRI
Representative Director, President; General Management, Leasing and Facilities-related Business
Mar 1974 Joined Ichinoyama Yakugyo Co., Ltd. Jan 1981 Joined Medical Yamagata Yakuhin Co., Ltd. Nov 1989 Assumed office as Representative Director, Medical Yamagata Yakuhin Co., Ltd. Jun 1991 Assumed office as Director, Akiyama Aiseikan Co., Ltd. (current Suzuken Co., Ltd.) Sep 1999 Established the Company; assumed office as Representative Director, President (current) Apr 2000 Assumed office as Chairperson, Nomad Social Welfare Corporation (current) Dec 2004 Assumed office as Representative Director, Nihon Leben Co., Ltd. Feb 2005 Assumed office as Representative Director, M&M Net Co., Ltd. Apr 2013 Assumed office as President, SMO Medicis Co., Ltd. Jul 2013 Assumed office as Representative Director, Vice President, H&M Co., Ltd. Jun 2015 Assumed office as Representative Director, President, H&M Co., Ltd. Jan 2016 Assumed office as Chairperson, Hokushikai Social Welfare Corporation Sep 2016 Assumed office as Representative Director, President, Felsen Pharma Co., Ltd. Oct 2017 Responsible for SCM Business Division and Development Business Division of the Company Jun 2019 Responsible for Leasing and Facilities-related Business of the Company (current) Jun 2020 Assumed office as Representative Director, Chairman, Felsen Pharma Co., Ltd. May 2024 Assumed office as Chairperson, Kōmei Gakuen School Corporation (current) Jun 2025 Assumed office as Director, Chairman, Felsen Pharma Co., Ltd. (current)
1948-05-20
Jiro AKINO
Representative Director, Vice President; General Management
Mar 1971 Joined Ichinoyama Yakugyo Co., Ltd. Jan 1983 Established Yugen-gaisha Ichino Akino; assumed office as Representative Director Sep 1999 Established the Company; assumed office as Representative Director, Managing Director Sep 2004 Assumed office as Representative Director, Pharma Holdings Co., Ltd. Jun 2015 Assumed office as Representative Director, Vice President of the Company (current) Oct 2017 Responsible for Pharmacy Business Division of the Company
1948-05-07
Yoshihiro TANAKA
Representative Director, Vice President; General Management, Community Pharmacy Network Business
Apr 1992 Joined Nippon Kogyo Bank, Ltd. (current Mizuho Bank, Ltd.) Jun 2006 Joined the Company; assumed office as General Manager, Corporate Planning Department Dec 2006 Assumed office as Director, General Manager, Corporate Planning Department Dec 2008 Assumed office as Managing Director, General Manager, Corporate Planning Department Oct 2012 Assumed office as Managing Director Jun 2015 Assumed office as Senior Managing Director Jun 2017 Assumed office as Director, Senior Executive Officer Oct 2017 Responsible for Corporate Strategy Division of the Company Jun 2019 Responsible for Community Pharmacy Network Business of the Company (current) Jun 2021 Assumed office as Representative Director, Vice President of the Company (current)
1969-12-04
Makoto SAKASHITA
Director, Senior Managing Executive Officer; in charge of Administration Division and Medical and Welfare Support Division
May 2001 Joined Pharma Holdings Co., Ltd. Dec 2004 Assumed office as Director of the Company Jun 2005 Assumed office as Representative Director, A.K.K. Co., Ltd. Dec 2005 Resigned as Director of the Company Dec 2007 Joined the Company; assumed office as General Manager, General Affairs Department Dec 2008 Assumed office as Director, General Manager, General Affairs Department Dec 2010 Assumed office as Managing Director, General Manager, General Affairs Department Apr 2012 Assumed office as Managing Director Jun 2015 Assumed office as Senior Managing Director Jun 2017 Assumed office as Director, Senior Executive Officer (current) Oct 2017 Assumed office as General Manager, Administration Division; General Manager, Medical and Welfare Support Division Jun 2024 Responsible for Administration Division of the Company (current) Jun 2026 Responsible for Medical and Welfare Support Division of the Company
1957-05-23
Kazuhiko SUMI
Director, Managing Executive Officer; in charge of Risk Management Office and Project Promotion Office
Apr 1986 Joined Yasuda Trust & Banking Co., Ltd. (current Mizuho Trust & Banking Co., Ltd.) Sep 2000 Assumed office as Director of the Company Apr 2002 Assumed office as Managing Director of the Company Jun 2005 Assumed office as Managing Director, General Manager, Project Promotion Office Jun 2017 Assumed office as Director, Managing Executive Officer (current) Oct 2017 Responsible for Risk Management Office of the Company (current) May 2020 Responsible for Project Promotion Office of the Company (current)
1963-01-23
Akira AOYAMA
Director, Managing Executive Officer; in charge of Systems Division
Apr 1980 Joined Suwa Seikosha Co., Ltd. (current Seiko Epson Corporation) Jan 1992 Assumed office as Director, Epson Medical Co., Ltd. (current E.M.Systems Co., Ltd.) Oct 1994 Assumed office as Managing Director, Epson Medical Co., Ltd. Jun 2002 Assumed office as Representative Director, Senior Managing Director, Epson Medical Co., Ltd. Nov 2012 Assumed office as Director, Vice President, Epson Medical Co., Ltd. Jun 2013 Assumed office as Managing Director of the Company Jun 2017 Assumed office as Director, Managing Executive Officer (current) Oct 2017 Assumed office as General Manager, Systems Division of the Company Apr 2019 Assumed office as General Manager, Pharmacy Systems Department of the Company Jun 2020 Assumed office as General Manager, Field Service Department of the Company Jun 2025 Responsible for Systems Division of the Company (current)
1957-02-23
Eiji HIRASHIMA
Director, Managing Executive Officer; Head of Accounting and Finance Division
Apr 1987 Joined Yasuda Trust & Banking Co., Ltd. (current Mizuho Trust & Banking Co., Ltd.) Sep 1999 Assumed office as Director of the Company Jun 2001 Assumed office as Director, General Manager, Administration Department Dec 2007 Assumed office as Director, General Manager, Finance Department Jun 2017 Assumed office as Director, Executive Officer, General Manager, Finance Department Jun 2021 Assumed office as Director, Managing Executive Officer (current) Jun 2021 Assumed office as Head of Accounting and Finance Division (current)
1961-12-02
Kentaro TAKO
Director, Managing Executive Officer; in charge of Systems Division, in charge of Food Service Business, Head of Corporate Strategy Division
Apr 1997 Joined Nippon Kogyo Bank, Ltd. (current Mizuho Bank, Ltd.) Apr 2002 Joined Mizuho Securities Co., Ltd. Sep 2015 Joined the Company Jan 2016 Assumed office as General Manager, Corporate Planning Department Jun 2016 Assumed office as Director, General Manager, Corporate Planning Department Jun 2017 Assumed office as Executive Officer, General Manager, Corporate Planning Department Oct 2017 Assumed office as Head of Corporate Strategy Division (current) Jun 2019 Assumed office as Director, Executive Officer; responsible for Food Service Business of the Company (current) Oct 2020 Assumed office as Representative Director, President, Pharmashift Co., Ltd. Jun 2024 Assumed office as Director, Managing Executive Officer (current) Jan 2025 Assumed office as Director, Farmo Co., Ltd. (current) Jun 2025 Responsible for Systems Division of the Company (current)
1974-05-29
Kenji SHIMIZU
Director, Executive Officer; Head of SCM Business Division
Apr 1984 Joined Sanseido Co., Ltd. (current Medipal Holdings Corporation) Apr 2020 Joined the Company; assumed office as Staff Manager, SCM Business Division Dec 2020 Assumed office as Executive Officer Dec 2020 Assumed office as Head of SCM Business Division (current) Jun 2023 Assumed office as Director, Executive Officer (current) Sep 2023 Assumed office as General Manager, Network Sales Department Apr 2024 Assumed office as General Manager, Distribution Promotion Department Jul 2024 Assumed office as General Manager, Marketing Department
1961-10-29
Akio KOIKE
Director
Jul 1969 Joined Japanese National Railways Apr 1987 Joined Hokkaido Railway Company; assumed office as General Manager, Management Planning Office, General Planning Headquarters Jun 1994 Assumed office as Director, Deputy General Manager, General Planning Headquarters, Hokkaido Railway Company Jun 2000 Assumed office as Representative Director, Senior Managing Director, General Manager, Development Business Headquarters, Hokkaido Railway Company Jun 2003 Assumed office as Representative Director, President, Hokkaido Railway Company Jun 2007 Assumed office as Representative Director, Chairman, Hokkaido Railway Company Nov 2011 Assumed office as Representative Director, President, Hokkaido Railway Company Jun 2013 Assumed office as Representative Director, Chairman, Hokkaido Railway Company Jun 2015 Assumed office as Director of the Company (current) May 2024 Assumed office as Outside Director, Arcs Co., Ltd. (current)
1946-07-28
Yuji MAEDA
Director, Audit and Supervisory Committee Member
Feb 1990 Registered as Certified Public Accountant Jul 2000 Assumed office as Director, Maeda CPA Office (current) Oct 2015 Assumed office as Director, One Nine Consulting Co., Ltd. (current) Mar 2016 Assumed office as Director (Audit and Supervisory Committee Member), Solxseeds Co., Ltd. Jul 2018 Assumed office as Partner, Taiyo LLC Audit Corporation Jun 2023 Assumed office as Director (Audit and Supervisory Committee Member) of the Company (current)
1958-10-18
Shuichi NAKAMURA
Director
Apr 1973 Joined Ministry of Health and Welfare Aug 2002 Assumed office as Director-General, Health Service Bureau, Ministry of Health, Labour and Welfare Aug 2005 Assumed office as Director-General, Social and Environmental Bureau, Ministry of Health, Labour and Welfare Sep 2008 Assumed office as President, Social Insurance Payment Fund (Shaho Shiharai Kikin) Oct 2010 Assumed office as Director-General, Office for Social Security Reform, Cabinet Secretariat Jan 2012 Assumed office as Chairman, Forum for Medical, Nursing and Welfare Policy Research (General Incorporated Association) (current) Apr 2012 Assumed office as Professor, Graduate School of International University of Health and Welfare (current) Jun 2014 Assumed office as Outside Director (Audit and Supervisory Committee Member), France Bed Holdings Co., Ltd. (current) Jun 2019 Assumed office as Director of the Company (current) Jun 2024 Assumed office as Chairperson, Ninjin no Kai Social Welfare Corporation (current)
1948-08-22
Toshiko IBU
Director
Apr 1969 Joined St. Luke's International Hospital Apr 1987 Assumed office as Lecturer, Japanese Red Cross College of Nursing May 1993 Assumed office as Director of Nursing and Vice Director, St. Luke's International Hospital Apr 2003 Assumed office as Professor, St. Luke's College of Nursing (current St. Luke's International University) Apr 2004 Assumed office as President, St. Luke's College of Nursing Apr 2012 Assumed office as Director, Forum for Medical, Nursing and Welfare Policy Research (General Incorporated Association) (current) Oct 2014 Assumed office as Representative Director, President, Japan Nursing Association Publishing Company, Ltd. (current) Apr 2016 Assumed office as Specially Appointed Professor, St. Luke's International University Apr 2017 Assumed office as Professor Emeritus, St. Luke's International University (current) Apr 2017 Assumed office as Representative Director, Ibu Nursing Management Research Institute Co., Ltd. (current) Apr 2019 Assumed office as Vice President and Dean, Faculty of Nursing, Nagano University of Health and Welfare Jun 2019 Assumed office as Director of the Company (current)
1947-01-03
Yukinobu MARUYAMA
Director
Apr 1986 Joined Fuji Bank, Ltd. (current Mizuho Bank, Ltd.) Apr 2015 Assumed office as General Manager, Tokyo Chuo Second Department, Tokyo Chuo Branch, Mizuho Bank, Ltd. Apr 2017 Assumed office as Executive Officer, General Manager, Tokyo Chuo Second Department, Tokyo Chuo Branch, Mizuho Bank, Ltd. Apr 2018 Assumed office as Managing Executive Officer, Sales Executive Officer, Mizuho Bank, Ltd. Apr 2020 Assumed office as Managing Executive Officer, Deputy Chief Executive, Retail and Corporate Business Company, Mizuho Financial Group, Inc.; Senior Managing Executive Officer, General Head, Retail and Corporate Business Division, Mizuho Bank, Ltd. Jul 2021 Assumed office as Executive Officer, Deputy Chief Executive, Retail and Corporate Business Company, Mizuho Financial Group, Inc.; Managing Executive Officer, General Head, Retail and Corporate Business Division, Mizuho Bank, Ltd. Apr 2022 Assumed office as Executive Officer, Mizuho Bank, Ltd. Jun 2022 Assumed office as Managing Director, East Japan Construction Business Guarantee Co., Ltd. (current) Jun 2026 Assumed office as Director of the Company
1962-07-09
Satoshi SATO
Director, Audit and Supervisory Committee Member
Apr 1983 Joined Hokkaido Prefectural Government Apr 2012 Assumed office as Director-General, Health, Safety and Hygiene Bureau, Department of Health and Welfare Apr 2014 Assumed office as Director-General, Living Safety Bureau, Department of Environment and Lifestyle Apr 2016 Assumed office as Deputy Director, Department of Construction Apr 2017 Assumed office as Director, Department of Health and Welfare Jun 2019 Assumed office as Director, General Affairs Department; Director, Northern Territories Countermeasures Headquarters Apr 2020 Assumed office as Audit Committee Member, Hokkaido Prefectural Government Jun 2022 Assumed office as Full-time Corporate Auditor of the Company Jun 2023 Assumed office as Director (Audit and Supervisory Committee Member) of the Company (current)
1960-09-07
Kengo SAITO
Director, Audit and Supervisory Committee Member
Apr 1989 Joined Fuji Bank, Ltd. (current Mizuho Bank, Ltd.) Apr 1991 Joined Sapporo City Government Apr 2017 Assumed office as Director, Northern City Tax Office, Tax Policy Division, Finance Bureau Apr 2019 Assumed office as Director-General, Environmental Business Division, Environment Bureau Apr 2021 Assumed office as Director-General, Tax Affairs Bureau, Finance Department Apr 2023 Assumed office as Director-General, Tax and Contract Management Bureau, Finance Department Jun 2025 Assumed office as Director (Audit and Supervisory Committee Member) of the Company (current)
1966-03-03
Yoshifumi YONEYA
Director, Audit and Supervisory Committee Member
Apr 1987 Registered as Attorney-at-law (Admitted to Sapporo Bar Association) Apr 1987 Joined Akio Hashimoto Law Office Apr 1991 Established Yoneya Law Office (current Yoneya & Hayashi Law Office) (current) Apr 2000 Assumed office as Corporate Auditor of the Company Sep 2000 Assumed office as Corporate Auditor, Nihon Leben Co., Ltd. Dec 2001 Assumed office as Corporate Auditor, Pharma Holdings Co., Ltd. Jun 2017 Assumed office as Corporate Auditor, System Four Co., Ltd. Jun 2023 Assumed office as Director (Audit and Supervisory Committee Member) of the Company (current)
1960-02-17
Large Shareholding Reports
Hikari Tsushin, Inc.
2026-11-04
7.32%→7.32%
Koutsushin Co., Ltd.
2026-10-06
7.32%→7.32%
Koutsushin Co., Ltd.
2026-09-14
7.32%→7.32%
Hikari Tsushin Inc.
2026-08-24
7.32%→7.32%
Hikari Tsushin, Inc.
2026-07-30
7.32%→7.32%
Koutsushin Co., Ltd.
2026-06-19
7.32%→7.32%
Koutsushin Co., Ltd.
2026-05-22
6.69%→7.32%
Koutsushin Co., Ltd.
2026-03-30
5.69%→6.69%
Koutsushin Co., Ltd.
2026-02-17
4.65%→5.69%
Koutsushin Co., Ltd.
2025-10-16
4.65%
Disclosures
No disclosures
Primary Source Filings
EDINET
2026-11-12
Semi-Annual Securities Report
Period: Apr 2026 – Mar 2027
TDnet
2026-11-10
Q2 Earnings Flash
FY ending Mar 2027
EDINET
2026-11-04
Large Shareholding Report
EDINET
2026-10-06
Large Shareholding Report
EDINET
2026-09-14
Large Shareholding Report
EDINET
2026-08-24
Large Shareholding Report
EDINETAmended
2026-08-18
Amended Annual Securities Report
Period: Apr 2025 – Mar 2026
TDnet
2026-08-07
Q1 Earnings Flash
FY ending Mar 2027
EDINET
2026-07-30
Large Shareholding Report
EDINET
2026-06-19
Annual Securities Report
Period: Apr 2025 – Mar 2026
EDINET
2026-06-19
Large Shareholding Report
EDINET
2026-05-22
Large Shareholding Report
TDnet
2026-05-08
特別損益
TDnet
2026-05-08
Full-Year Earnings Flash
FY ending Mar 2026
EDINET
2026-03-30
Large Shareholding Report
EDINET
2026-02-17
Large Shareholding Report
TDnet
2026-02-06
Q3 Earnings Flash
FY ending Mar 2026
EDINET
2025-11-11
Semi-Annual Securities Report
Period: Apr 2025 – Mar 2026
TDnet
2025-11-07
業績予想の修正
FY ending Mar 2026
EDINET
2025-10-16
Large Shareholding Report
TDnet
2025-08-08
Q1 Earnings Flash
FY ending Mar 2026
EDINET
2025-06-23
Annual Securities Report
Period: Apr 2024 – Mar 2025
TDnet
2025-02-07
Q3 Earnings Flash
FY ending Mar 2025
EDINET
2024-11-12
Semi-Annual Securities Report
Period: Apr 2024 – Mar 2025
TDnet
2024-08-07
Q1 Earnings Flash
FY ending Mar 2025
EDINET
2024-06-21
Annual Securities Report
Period: Apr 2023 – Mar 2024
EDINET
2024-05-10
Securities Registration Statement
EDINET
2024-02-08
Quarterly Securities Report
Period: Oct 2023 – Dec 2023
EDINET
2023-11-09
Quarterly Securities Report
Period: Jul 2023 – Sep 2023
EDINET
2023-08-10
Quarterly Securities Report
Period: Apr 2023 – Jun 2023
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
Ask me!
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →